Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-29

Clinical Trial Update: Efficacy and Safety for Cimicifuga/Hypericum Product [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy and safety of a Cimicifuga/Hypericum product for perimenopausal disorder; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cimicifuga/Hypericum product

Snippet

Sponsor: Phytopharm Consulting Brazil | Conditions: Perimenopausal Disorder | Phase 3 | Status: UNKNOWN